2-(3,5-Dibromo-4-hydroxyphenyl)imidazo[4,5-f][1,10]phenanthrolinoruthenium(II) complexes: synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity

Research Progress of Metal Anticancer Drugs

Cancer treatments, including traditional chemotherapy, have failed to cure human malignancies. The main reasons for the failure of these treatments are the inevitable drug resistance and serious side effects. In clinical treatment, only 5 percent of the 50 percent of cancer patients who are able to receive conventional chemotherapy survive. Because of these factors, being able to develop a drug and treatment that can target only cancer cells without affecting normal cells remains a big challenge. Since the special properties of cisplatin in the treatment of malignant tumors were accidentally discovered in the last century, metal anticancer drugs have become a research hotspot. Metal anticancer drugs have unique pharmaceutical properties, such as ruthenium metal drugs with their high selectivity, low toxicity, easy absorption by tumor tissue, excretion, and so on. In recent years, efficient and low-toxicity metal antitumor complexes have been synthesized. In this paper, the scientific literature on platinum (Pt), ruthenium (Ru), iridium (Ir), gold (Au), and other anticancer complexes was reviewed by referring to a large amount of relevant literature at home and abroad.

Two new mixed copper(ii)–dipeptide complexes of N,N-donor heterocycle ligands: studies on their non-covalent DNA binding, chemical nuclease, antioxidant and anticancer activities

Two novel mononuclear mixed ligand copper(ii)-dipeptide complexes have been synthesized. The DNA interactions of the complexes were investigated. In addition, the antioxidant and antitumor activities of the complexes were evaluated.

Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex

Radiation has large influence on the cytotoxicity, apoptosis and cell cycle arrest. The bioactivity of ruthenium(II) complex [Ru(dmb)2(DBHIP)](ClO4)2 (Ru1) (DBHIP=2-(3,5-dibromo-4-hydroxylphenyl)imidazo[4,5-f][1,10]phenanthroline) was investigated in the absence and presence of radiation. The cytotoxicity of Ru1 against MG-63 cells was evaluated by CCK-8 method. Ru1 shows high cytotoxicity upon radiation. Radiation can enhance the cytotoxicity of Ru1 on MG-63 cells. The apoptosis was studied by Hoechst 33258 staining method and flow cytometry. The reactive oxygen species, mitochondrial membrane potential, cell cycle arrest and western blot analysis were investigated in detail. The complex induces the apoptosis in MG-63 cells through ROS-mediated mitochondrial dysfunction pathway.

Lanthanide-Based Polymers with Charged Ligand Backbones: Triple-Stranded Chain Structures and their DNA Cleavage Studies

Four rare-earth metal complexes, [Ln(Ccbp)3(H2O)3]n (Ln = La (1), Ce (2), Pr (3) and Nd (4)) are synthesised from the ligand H2CcbpBr (H2CcbpBr = 4-carboxy-1-(4-carboxybenzyl)pyridinium bromide) and the respective lanthanide metal ions. Complexes 1–4 are isostructural in that every three Ccbp– ligands juxtapose two Ln3+ ions in a monodentate coordination mode to form triple-stranded one-dimensional chain structures. Each central Ln3+ atom further associates with three H2O molecules, furnishing a monocapped square-antiprism geometry. Agarose gel electrophoresis studies indicate that 1–4 are capable of cleaving DNA in the presence of H2O2, most probably via an oxidative cleavage mechanism. Complexes 1 and 2 exhibited catalytic efficiencies (kmax/KM) of 37.69 and 34.11 h–1 mM–1, and are approx. 15- and 20-fold more effective than those of complexes 3 (kmax/KM = 1.75 h–1 mM–1) and 4 (kmax/KM = 2.21 h–1 mM–1).

Synthesis of 1,3,5-trisubstituted pyrazoline derivatives and their applications

The biological activities of pyrazoline based Ru(iii) complexes were carried out using gel electrophoresis, absorption titration, cellular level cytotoxicity and molecular docking study. Compounds exhibit potent nuclease and cytotoxicity activity.

Mechanism of DNA Cleavage Catalysed by the System Comprising an Unsaturated Tetraaza Macrocycle and La(III) and Ce(III) Ions

In order to further the design of efficient artificial nuclease models for hydrolytic cleavage of DNA, the catalytic system made from an unsaturated tetraaza macrocycle and La(III) and Ce(III) ions was constructed and used as catalyst in the cleavage of plasmid PUC19 DNA. The interactions of these catalytic systems with plasmid PUC19 DNA has been investigated by UV-Vis absorption spectroscopy, fluorescence spectroscopy, cyclic voltammetry and gel electrophoresis. The results show that the combination of the catalytic system with DNA involves electrostatic binding through the phosphodiester linkages of DNA. The gel electrophoresis results also showed that supercoiled PUC19 plasmid DNA (cccDNA) was converted to the nicked form of DNA (ocDNA) under a nitrogen atmosphere. On the basis of these results, a mechanism for the catalytic cleavage of DNA is proposed.

Cationic ruthenium(III) maltolato–imidazole complexes — Synthesis, characterization, and antiproliferatory activity*Adapted from the Ph.D. thesis of D.C. Kennedy (see the References section)

The cationic RuIII complexes, trans-[Ru(ma)2(L)2]CF3SO3, where Hma = maltol = 3-hydroxy-2-methyl-4-pyrone; L = imidazole (Im) (complex 2), 1(N)-methylimidazole (N-MeIm) (3), 2-methylimidazole (2-MeIm) (4), and 4-methylimidazole (4-MeIm) (5), were synthesized via the known L = EtOH (complex 1a), and characterized by elemental analysis, 1H NMR and IR spectroscopies, mass spectrometry, cyclic voltammetry, and (for 3 and 4) by X-ray crystallography. The trans-[Ru(ma)2(H2O)2]CF3SO3 complex (1b) was inadvertently isolated and characterized crystallographically, and the monomaltolato species [Ru(ma)(N-MeIm)4][CF3SO3]2 (6) was also isolated and characterized. In vitro antiproliferatory activity of complexes 2−6 against human breast cancer cells (MDA-MB-435S) was tested using an MTT assay: 4 and 5 exhibit the lowest IC50 values, ~5 and ~15 µmol/L, respectively, whereas cisplatin exhibits an IC50 value of ~35 µmol/L against this cell line.